Catalyst Wire Dossier Catalyst Wire Dossier

Ranolazine (Ranexa)

Ranolazine · Gilead Sciences
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Ranolazine (Ranexa), covering 2013-09-23 to 2017-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction [Phase 4]

See pricing